nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—migraine—Prednisone—psoriatic arthritis	0.842	1	CpDpCtD
Tizanidine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000192	0.00122	CcSEcCtD
Tizanidine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000192	0.00121	CcSEcCtD
Tizanidine—Shock—Prednisolone—psoriatic arthritis	0.000191	0.00121	CcSEcCtD
Tizanidine—Convulsion—Triamcinolone—psoriatic arthritis	0.000189	0.0012	CcSEcCtD
Tizanidine—Tachycardia—Prednisolone—psoriatic arthritis	0.000189	0.0012	CcSEcCtD
Tizanidine—Convulsion—Methylprednisolone—psoriatic arthritis	0.000189	0.0012	CcSEcCtD
Tizanidine—Hypertension—Triamcinolone—psoriatic arthritis	0.000189	0.0012	CcSEcCtD
Tizanidine—Hypertension—Methylprednisolone—psoriatic arthritis	0.000188	0.00119	CcSEcCtD
Tizanidine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000188	0.00119	CcSEcCtD
Tizanidine—Pneumonia—Methotrexate—psoriatic arthritis	0.000186	0.00118	CcSEcCtD
Tizanidine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000186	0.00118	CcSEcCtD
Tizanidine—Anxiety—Methylprednisolone—psoriatic arthritis	0.000185	0.00117	CcSEcCtD
Tizanidine—Drowsiness—Methotrexate—psoriatic arthritis	0.000185	0.00117	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000185	0.00117	CcSEcCtD
Tizanidine—Depression—Methotrexate—psoriatic arthritis	0.000184	0.00117	CcSEcCtD
Tizanidine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000184	0.00117	CcSEcCtD
Tizanidine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000184	0.00117	CcSEcCtD
Tizanidine—Discomfort—Triamcinolone—psoriatic arthritis	0.000184	0.00116	CcSEcCtD
Tizanidine—Discomfort—Methylprednisolone—psoriatic arthritis	0.000184	0.00116	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000183	0.00116	CcSEcCtD
Tizanidine—Dry mouth—Triamcinolone—psoriatic arthritis	0.000182	0.00115	CcSEcCtD
Tizanidine—Renal failure—Methotrexate—psoriatic arthritis	0.000182	0.00115	CcSEcCtD
Tizanidine—Angiopathy—Prednisone—psoriatic arthritis	0.00018	0.00114	CcSEcCtD
Tizanidine—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00018	0.00114	CcSEcCtD
Tizanidine—Confusional state—Methylprednisolone—psoriatic arthritis	0.00018	0.00114	CcSEcCtD
Tizanidine—Immune system disorder—Prednisone—psoriatic arthritis	0.000179	0.00114	CcSEcCtD
Tizanidine—Malaise—Betamethasone—psoriatic arthritis	0.000179	0.00113	CcSEcCtD
Tizanidine—Malaise—Dexamethasone—psoriatic arthritis	0.000179	0.00113	CcSEcCtD
Tizanidine—Oedema—Triamcinolone—psoriatic arthritis	0.000178	0.00113	CcSEcCtD
Tizanidine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000178	0.00113	CcSEcCtD
Tizanidine—Vertigo—Dexamethasone—psoriatic arthritis	0.000178	0.00113	CcSEcCtD
Tizanidine—Vertigo—Betamethasone—psoriatic arthritis	0.000178	0.00113	CcSEcCtD
Tizanidine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000178	0.00113	CcSEcCtD
Tizanidine—Syncope—Dexamethasone—psoriatic arthritis	0.000178	0.00113	CcSEcCtD
Tizanidine—Syncope—Betamethasone—psoriatic arthritis	0.000178	0.00113	CcSEcCtD
Tizanidine—Arrhythmia—Prednisone—psoriatic arthritis	0.000177	0.00112	CcSEcCtD
Tizanidine—Infection—Triamcinolone—psoriatic arthritis	0.000177	0.00112	CcSEcCtD
Tizanidine—Sweating—Methotrexate—psoriatic arthritis	0.000177	0.00112	CcSEcCtD
Tizanidine—Infection—Methylprednisolone—psoriatic arthritis	0.000177	0.00112	CcSEcCtD
Tizanidine—Haematuria—Methotrexate—psoriatic arthritis	0.000176	0.00112	CcSEcCtD
Tizanidine—Shock—Triamcinolone—psoriatic arthritis	0.000176	0.00111	CcSEcCtD
Tizanidine—Alopecia—Prednisone—psoriatic arthritis	0.000175	0.00111	CcSEcCtD
Tizanidine—Shock—Methylprednisolone—psoriatic arthritis	0.000175	0.00111	CcSEcCtD
Tizanidine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000175	0.00111	CcSEcCtD
Tizanidine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000175	0.00111	CcSEcCtD
Tizanidine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000174	0.0011	CcSEcCtD
Tizanidine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000174	0.0011	CcSEcCtD
Tizanidine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000174	0.0011	CcSEcCtD
Tizanidine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000174	0.0011	CcSEcCtD
Tizanidine—Mental disorder—Prednisone—psoriatic arthritis	0.000174	0.0011	CcSEcCtD
Tizanidine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000174	0.0011	CcSEcCtD
Tizanidine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000173	0.0011	CcSEcCtD
Tizanidine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000173	0.00109	CcSEcCtD
Tizanidine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000172	0.00109	CcSEcCtD
Tizanidine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000172	0.00109	CcSEcCtD
Tizanidine—Convulsion—Dexamethasone—psoriatic arthritis	0.000172	0.00109	CcSEcCtD
Tizanidine—Convulsion—Betamethasone—psoriatic arthritis	0.000172	0.00109	CcSEcCtD
Tizanidine—Hypertension—Dexamethasone—psoriatic arthritis	0.000171	0.00108	CcSEcCtD
Tizanidine—Hypertension—Betamethasone—psoriatic arthritis	0.000171	0.00108	CcSEcCtD
Tizanidine—Anxiety—Betamethasone—psoriatic arthritis	0.000168	0.00107	CcSEcCtD
Tizanidine—Anxiety—Dexamethasone—psoriatic arthritis	0.000168	0.00107	CcSEcCtD
Tizanidine—Discomfort—Betamethasone—psoriatic arthritis	0.000167	0.00106	CcSEcCtD
Tizanidine—Discomfort—Dexamethasone—psoriatic arthritis	0.000167	0.00106	CcSEcCtD
Tizanidine—Haemoglobin—Methotrexate—psoriatic arthritis	0.000167	0.00106	CcSEcCtD
Tizanidine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000166	0.00105	CcSEcCtD
Tizanidine—Haemorrhage—Methotrexate—psoriatic arthritis	0.000166	0.00105	CcSEcCtD
Tizanidine—Hepatitis—Methotrexate—psoriatic arthritis	0.000166	0.00105	CcSEcCtD
Tizanidine—Pharyngitis—Methotrexate—psoriatic arthritis	0.000165	0.00104	CcSEcCtD
Tizanidine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000164	0.00104	CcSEcCtD
Tizanidine—Vision blurred—Prednisone—psoriatic arthritis	0.000163	0.00103	CcSEcCtD
Tizanidine—Urethral disorder—Methotrexate—psoriatic arthritis	0.000163	0.00103	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000163	0.00103	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000162	0.00103	CcSEcCtD
Tizanidine—Oedema—Dexamethasone—psoriatic arthritis	0.000162	0.00103	CcSEcCtD
Tizanidine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000162	0.00103	CcSEcCtD
Tizanidine—Oedema—Betamethasone—psoriatic arthritis	0.000162	0.00103	CcSEcCtD
Tizanidine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000162	0.00103	CcSEcCtD
Tizanidine—Infection—Dexamethasone—psoriatic arthritis	0.000161	0.00102	CcSEcCtD
Tizanidine—Infection—Betamethasone—psoriatic arthritis	0.000161	0.00102	CcSEcCtD
Tizanidine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00016	0.00102	CcSEcCtD
Tizanidine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00016	0.00101	CcSEcCtD
Tizanidine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00016	0.00101	CcSEcCtD
Tizanidine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00016	0.00101	CcSEcCtD
Tizanidine—Anaemia—Prednisone—psoriatic arthritis	0.00016	0.00101	CcSEcCtD
Tizanidine—Shock—Betamethasone—psoriatic arthritis	0.000159	0.00101	CcSEcCtD
Tizanidine—Shock—Dexamethasone—psoriatic arthritis	0.000159	0.00101	CcSEcCtD
Tizanidine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000159	0.00101	CcSEcCtD
Tizanidine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000159	0.00101	CcSEcCtD
Tizanidine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000159	0.00101	CcSEcCtD
Tizanidine—Agitation—Prednisone—psoriatic arthritis	0.000159	0.00101	CcSEcCtD
Tizanidine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000159	0.001	CcSEcCtD
Tizanidine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000159	0.001	CcSEcCtD
Tizanidine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000158	0.001	CcSEcCtD
Tizanidine—Tachycardia—Betamethasone—psoriatic arthritis	0.000158	0.001	CcSEcCtD
Tizanidine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000157	0.000995	CcSEcCtD
Tizanidine—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000157	0.000993	CcSEcCtD
Tizanidine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000157	0.000993	CcSEcCtD
Tizanidine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000157	0.000991	CcSEcCtD
Tizanidine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000157	0.000991	CcSEcCtD
Tizanidine—Malaise—Prednisone—psoriatic arthritis	0.000156	0.000987	CcSEcCtD
Tizanidine—Vertigo—Prednisone—psoriatic arthritis	0.000155	0.000983	CcSEcCtD
Tizanidine—Syncope—Prednisone—psoriatic arthritis	0.000155	0.000981	CcSEcCtD
Tizanidine—Tinnitus—Methotrexate—psoriatic arthritis	0.000155	0.000979	CcSEcCtD
Tizanidine—Urticaria—Prednisolone—psoriatic arthritis	0.000154	0.000976	CcSEcCtD
Tizanidine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000154	0.000975	CcSEcCtD
Tizanidine—Fatigue—Triamcinolone—psoriatic arthritis	0.000154	0.000974	CcSEcCtD
Tizanidine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000154	0.000972	CcSEcCtD
Tizanidine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000152	0.000962	CcSEcCtD
Tizanidine—Hypotension—Betamethasone—psoriatic arthritis	0.000151	0.000958	CcSEcCtD
Tizanidine—Hypotension—Dexamethasone—psoriatic arthritis	0.000151	0.000958	CcSEcCtD
Tizanidine—Angiopathy—Methotrexate—psoriatic arthritis	0.000151	0.000953	CcSEcCtD
Tizanidine—Immune system disorder—Methotrexate—psoriatic arthritis	0.00015	0.000949	CcSEcCtD
Tizanidine—Convulsion—Prednisone—psoriatic arthritis	0.00015	0.000948	CcSEcCtD
Tizanidine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00015	0.000947	CcSEcCtD
Tizanidine—Hypertension—Prednisone—psoriatic arthritis	0.000149	0.000945	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000148	0.000934	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000148	0.000934	CcSEcCtD
Tizanidine—Arthralgia—Prednisone—psoriatic arthritis	0.000147	0.000932	CcSEcCtD
Tizanidine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000147	0.000931	CcSEcCtD
Tizanidine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000147	0.000929	CcSEcCtD
Tizanidine—Anxiety—Prednisone—psoriatic arthritis	0.000147	0.000928	CcSEcCtD
Tizanidine—Alopecia—Methotrexate—psoriatic arthritis	0.000147	0.000928	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000146	0.000925	CcSEcCtD
Tizanidine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000146	0.000922	CcSEcCtD
Tizanidine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000145	0.000921	CcSEcCtD
Tizanidine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000145	0.000921	CcSEcCtD
Tizanidine—Discomfort—Prednisone—psoriatic arthritis	0.000145	0.00092	CcSEcCtD
Tizanidine—Mental disorder—Methotrexate—psoriatic arthritis	0.000145	0.00092	CcSEcCtD
Tizanidine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000143	0.000905	CcSEcCtD
Tizanidine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000143	0.000903	CcSEcCtD
Tizanidine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000143	0.000903	CcSEcCtD
Tizanidine—Urticaria—Triamcinolone—psoriatic arthritis	0.000142	0.000898	CcSEcCtD
Tizanidine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000141	0.000896	CcSEcCtD
Tizanidine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000141	0.000893	CcSEcCtD
Tizanidine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000141	0.000893	CcSEcCtD
Tizanidine—Oedema—Prednisone—psoriatic arthritis	0.000141	0.000893	CcSEcCtD
Tizanidine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000141	0.000891	CcSEcCtD
Tizanidine—Infection—Prednisone—psoriatic arthritis	0.00014	0.000887	CcSEcCtD
Tizanidine—Back pain—Methotrexate—psoriatic arthritis	0.00014	0.000885	CcSEcCtD
Tizanidine—Fatigue—Dexamethasone—psoriatic arthritis	0.00014	0.000884	CcSEcCtD
Tizanidine—Fatigue—Betamethasone—psoriatic arthritis	0.00014	0.000884	CcSEcCtD
Tizanidine—Shock—Prednisone—psoriatic arthritis	0.000139	0.000879	CcSEcCtD
Tizanidine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000138	0.000876	CcSEcCtD
Tizanidine—Tachycardia—Prednisone—psoriatic arthritis	0.000138	0.000872	CcSEcCtD
Tizanidine—Skin disorder—Prednisone—psoriatic arthritis	0.000137	0.000867	CcSEcCtD
Tizanidine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000136	0.000863	CcSEcCtD
Tizanidine—Vision blurred—Methotrexate—psoriatic arthritis	0.000136	0.000862	CcSEcCtD
Tizanidine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000134	0.000848	CcSEcCtD
Tizanidine—Anaemia—Methotrexate—psoriatic arthritis	0.000133	0.000845	CcSEcCtD
Tizanidine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000133	0.000845	CcSEcCtD
Tizanidine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000133	0.000845	CcSEcCtD
Tizanidine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000132	0.000839	CcSEcCtD
Tizanidine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000132	0.000839	CcSEcCtD
Tizanidine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000132	0.000833	CcSEcCtD
Tizanidine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000131	0.000831	CcSEcCtD
Tizanidine—Malaise—Methotrexate—psoriatic arthritis	0.00013	0.000825	CcSEcCtD
Tizanidine—Vertigo—Methotrexate—psoriatic arthritis	0.00013	0.000822	CcSEcCtD
Tizanidine—Leukopenia—Methotrexate—psoriatic arthritis	0.000129	0.000819	CcSEcCtD
Tizanidine—Urticaria—Dexamethasone—psoriatic arthritis	0.000129	0.000815	CcSEcCtD
Tizanidine—Urticaria—Betamethasone—psoriatic arthritis	0.000129	0.000815	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000129	0.000814	CcSEcCtD
Tizanidine—Dizziness—Prednisolone—psoriatic arthritis	0.000128	0.000813	CcSEcCtD
Tizanidine—Asthenia—Triamcinolone—psoriatic arthritis	0.000128	0.000811	CcSEcCtD
Tizanidine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000128	0.000811	CcSEcCtD
Tizanidine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000128	0.000811	CcSEcCtD
Tizanidine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000128	0.000811	CcSEcCtD
Tizanidine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000128	0.000811	CcSEcCtD
Tizanidine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000128	0.000809	CcSEcCtD
Tizanidine—Paraesthesia—Prednisone—psoriatic arthritis	0.000127	0.000802	CcSEcCtD
Tizanidine—Pruritus—Triamcinolone—psoriatic arthritis	0.000126	0.0008	CcSEcCtD
Tizanidine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000126	0.000798	CcSEcCtD
Tizanidine—Convulsion—Methotrexate—psoriatic arthritis	0.000125	0.000792	CcSEcCtD
Tizanidine—Dyspepsia—Prednisone—psoriatic arthritis	0.000124	0.000786	CcSEcCtD
Tizanidine—Arthralgia—Methotrexate—psoriatic arthritis	0.000123	0.000779	CcSEcCtD
Tizanidine—Rash—Prednisolone—psoriatic arthritis	0.000122	0.000775	CcSEcCtD
Tizanidine—Dermatitis—Prednisolone—psoriatic arthritis	0.000122	0.000774	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000122	0.000773	CcSEcCtD
Tizanidine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000122	0.000772	CcSEcCtD
Tizanidine—Fatigue—Prednisone—psoriatic arthritis	0.000122	0.00077	CcSEcCtD
Tizanidine—Discomfort—Methotrexate—psoriatic arthritis	0.000121	0.000769	CcSEcCtD
Tizanidine—Constipation—Prednisone—psoriatic arthritis	0.000121	0.000764	CcSEcCtD
Tizanidine—Confusional state—Methotrexate—psoriatic arthritis	0.000119	0.000753	CcSEcCtD
Tizanidine—Dizziness—Triamcinolone—psoriatic arthritis	0.000118	0.000747	CcSEcCtD
Tizanidine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000118	0.000746	CcSEcCtD
Tizanidine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000118	0.000746	CcSEcCtD
Tizanidine—Infection—Methotrexate—psoriatic arthritis	0.000117	0.000741	CcSEcCtD
Tizanidine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000116	0.000736	CcSEcCtD
Tizanidine—Asthenia—Betamethasone—psoriatic arthritis	0.000116	0.000736	CcSEcCtD
Tizanidine—Asthenia—Dexamethasone—psoriatic arthritis	0.000116	0.000736	CcSEcCtD
Tizanidine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000116	0.000732	CcSEcCtD
Tizanidine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000115	0.000731	CcSEcCtD
Tizanidine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000115	0.00073	CcSEcCtD
Tizanidine—Nausea—Prednisolone—psoriatic arthritis	0.000115	0.00073	CcSEcCtD
Tizanidine—Pruritus—Dexamethasone—psoriatic arthritis	0.000115	0.000725	CcSEcCtD
Tizanidine—Pruritus—Betamethasone—psoriatic arthritis	0.000115	0.000725	CcSEcCtD
Tizanidine—Skin disorder—Methotrexate—psoriatic arthritis	0.000114	0.000725	CcSEcCtD
Tizanidine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000114	0.000721	CcSEcCtD
Tizanidine—Vomiting—Triamcinolone—psoriatic arthritis	0.000113	0.000719	CcSEcCtD
Tizanidine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000113	0.000717	CcSEcCtD
Tizanidine—Rash—Triamcinolone—psoriatic arthritis	0.000113	0.000713	CcSEcCtD
Tizanidine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000112	0.000712	CcSEcCtD
Tizanidine—Rash—Methylprednisolone—psoriatic arthritis	0.000112	0.000711	CcSEcCtD
Tizanidine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000112	0.00071	CcSEcCtD
Tizanidine—Urticaria—Prednisone—psoriatic arthritis	0.000112	0.000709	CcSEcCtD
Tizanidine—Body temperature increased—Prednisone—psoriatic arthritis	0.000111	0.000706	CcSEcCtD
Tizanidine—Abdominal pain—Prednisone—psoriatic arthritis	0.000111	0.000706	CcSEcCtD
Tizanidine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000111	0.000702	CcSEcCtD
Tizanidine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000111	0.000702	CcSEcCtD
Tizanidine—Hypotension—Methotrexate—psoriatic arthritis	0.00011	0.000697	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000107	0.00068	CcSEcCtD
Tizanidine—Dizziness—Betamethasone—psoriatic arthritis	0.000107	0.000678	CcSEcCtD
Tizanidine—Dizziness—Dexamethasone—psoriatic arthritis	0.000107	0.000678	CcSEcCtD
Tizanidine—Nausea—Triamcinolone—psoriatic arthritis	0.000106	0.000671	CcSEcCtD
Tizanidine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000106	0.00067	CcSEcCtD
Tizanidine—Nausea—Methylprednisolone—psoriatic arthritis	0.000106	0.00067	CcSEcCtD
Tizanidine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000105	0.000665	CcSEcCtD
Tizanidine—Somnolence—Methotrexate—psoriatic arthritis	0.000105	0.000663	CcSEcCtD
Tizanidine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000104	0.000658	CcSEcCtD
Tizanidine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000104	0.000657	CcSEcCtD
Tizanidine—Vomiting—Dexamethasone—psoriatic arthritis	0.000103	0.000652	CcSEcCtD
Tizanidine—Vomiting—Betamethasone—psoriatic arthritis	0.000103	0.000652	CcSEcCtD
Tizanidine—Rash—Dexamethasone—psoriatic arthritis	0.000102	0.000647	CcSEcCtD
Tizanidine—Rash—Betamethasone—psoriatic arthritis	0.000102	0.000647	CcSEcCtD
Tizanidine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000102	0.000646	CcSEcCtD
Tizanidine—Dermatitis—Betamethasone—psoriatic arthritis	0.000102	0.000646	CcSEcCtD
Tizanidine—Fatigue—Methotrexate—psoriatic arthritis	0.000102	0.000643	CcSEcCtD
Tizanidine—Asthenia—Prednisone—psoriatic arthritis	0.000101	0.000641	CcSEcCtD
Tizanidine—Pruritus—Prednisone—psoriatic arthritis	9.98e-05	0.000632	CcSEcCtD
Tizanidine—Feeling abnormal—Methotrexate—psoriatic arthritis	9.71e-05	0.000615	CcSEcCtD
Tizanidine—Diarrhoea—Prednisone—psoriatic arthritis	9.65e-05	0.000611	CcSEcCtD
Tizanidine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	9.64e-05	0.00061	CcSEcCtD
Tizanidine—Nausea—Betamethasone—psoriatic arthritis	9.62e-05	0.000609	CcSEcCtD
Tizanidine—Nausea—Dexamethasone—psoriatic arthritis	9.62e-05	0.000609	CcSEcCtD
Tizanidine—Urticaria—Methotrexate—psoriatic arthritis	9.36e-05	0.000593	CcSEcCtD
Tizanidine—Dizziness—Prednisone—psoriatic arthritis	9.33e-05	0.000591	CcSEcCtD
Tizanidine—Body temperature increased—Methotrexate—psoriatic arthritis	9.32e-05	0.00059	CcSEcCtD
Tizanidine—Abdominal pain—Methotrexate—psoriatic arthritis	9.32e-05	0.00059	CcSEcCtD
Tizanidine—Vomiting—Prednisone—psoriatic arthritis	8.97e-05	0.000568	CcSEcCtD
Tizanidine—Rash—Prednisone—psoriatic arthritis	8.89e-05	0.000563	CcSEcCtD
Tizanidine—Dermatitis—Prednisone—psoriatic arthritis	8.88e-05	0.000563	CcSEcCtD
Tizanidine—Hypersensitivity—Methotrexate—psoriatic arthritis	8.68e-05	0.00055	CcSEcCtD
Tizanidine—Asthenia—Methotrexate—psoriatic arthritis	8.46e-05	0.000535	CcSEcCtD
Tizanidine—Nausea—Prednisone—psoriatic arthritis	8.38e-05	0.00053	CcSEcCtD
Tizanidine—Pruritus—Methotrexate—psoriatic arthritis	8.34e-05	0.000528	CcSEcCtD
Tizanidine—Diarrhoea—Methotrexate—psoriatic arthritis	8.07e-05	0.000511	CcSEcCtD
Tizanidine—Dizziness—Methotrexate—psoriatic arthritis	7.79e-05	0.000494	CcSEcCtD
Tizanidine—Vomiting—Methotrexate—psoriatic arthritis	7.49e-05	0.000475	CcSEcCtD
Tizanidine—Rash—Methotrexate—psoriatic arthritis	7.43e-05	0.000471	CcSEcCtD
Tizanidine—Dermatitis—Methotrexate—psoriatic arthritis	7.43e-05	0.00047	CcSEcCtD
Tizanidine—Nausea—Methotrexate—psoriatic arthritis	7e-05	0.000443	CcSEcCtD
